درباره این اپیزود
Form Bio CEO Michelle Chen, PhD, talks with ARM CEO Tim Hunt at Meeting on the Mesa 2026 about rebounding investment, regulatory shifts, manufacturing and AI, and what's next for cell and gene therapy.
انگلیسی
انگلستان
رونوشت 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
جستجوی اپیزودهای گذشته
اپیزودهای قبلی The Algorithm of Life را جستجو کن.
قسمت های دیگر در این پادکست
Join us for a conversation with veteran biotech leader Dr. Len Post as he reflects on a remarkable career spanning infectious disease, oncology, rare disease, gene therapy, and biotech innovation. Dr. Post shares his journey from molecular biologist to R&D executive, offering lessons learned fr…
Michelle Chen, CEO of Form Bio, sits down with George Church — Harvard geneticist, serial entrepreneur, and one of the founding minds behind personal genomics, synthetic biology, and de-extinction — for a wide-ranging conversation on where biology is headed next. Church reflects on picking research…
What does it take to see the next wave before it arrives?
Michelle Chen, Form Bio's CEO, sits down with systems biology pioneer Lee Hood at SynBioBeta to discuss the bold scientific bets that shaped modern biotechnology, from automated DNA sequencing to the Human Genome Project and precision healt…
Michelle Chen, CEO at Form Bio, sits down with Richard Horgan, Founder and CEO of the Cure Rare Disease Foundation, to share a deeply personal story that became a mission, accelerating cell and gene therapy development for ultra-rare diseases.
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به Form Bio است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.
ویرایش
از کمک شما برای بروز نگهداشتن پایگاهدادههای پادکست سپاسگزاریم
